NewsBite

Street Talk

Eyes on franchisee sell orders ahead of Chemist Warehouse’s ASX debut

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Will it be a bloodbath or a mass christening of millionaires at Sigma Pharmaceuticals on Thursday as Chemist Warehouse commences trading and its un-escrowed franchisees are allowed to sell out?

The $4.5 billion pharmaceutical distributor Sigma Healthcare is one sleep away from becoming the new $30 billion home to pharmacy behemoth Chemist Warehouse.

Loading...
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Kanika Sood is a journalist based in Sydney who writes for the Street Talk column. Email Kanika at kanika.sood@afr.com.au
Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review. Connect with Emma on Twitter. Email Emma at emma.rapaport@afr.com

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Read More

Original URL: https://www.afr.com/street-talk/eyes-on-franchisee-sell-orders-ahead-of-chemist-warehouse-s-asx-debut-20250212-p5lbje